Endocrine function of adipose tissue and its clinical use: still waiting for the prime time?

References

• Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation106, 286–288 (2002).
   PubMed Web of Science ®Google Scholar
• Reaven GM. Syndrome X. Blood Press.4(Suppl.), 13–16 (1992).
   Google Scholar
• Haffner SM, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med.339, 229–234 (1998).
   PubMed Web of Science ®Google Scholar
• Howard G, O’Leary DH, Zaccaro D et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation93, 1809–1817 (1996).
   PubMed Web of Science ®Google Scholar
• Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm. Metab. Res.35, 337–342 (2003).
   PubMedGoogle Scholar
• Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway – a link between adipose tissue mass and central neural networks. Horm. Metab. Res.28, 619–632 (1996).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science259, 87–91 (1993).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Arne P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest.95, 2409–2415 (1995).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature372, 425–432 (1994).
   PubMed Web of Science ®Google Scholar
• Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med.1, 1155–1161 (1995).
   PubMed Web of Science ®Google Scholar
• Farooqi IS, Matarese G, Lord G.M et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest.110, 1093–1103 (2002).
   PubMed Web of Science ®Google Scholar
• Moitra J, Mason MM, Olive M et al. Life without white fat: a transgenic mouse. Genes Dev.12, 3168–3181 (1998).
   PubMed Web of Science ®Google Scholar
• Gavrilova O, Marcus-Samuels B, Graham D et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J. Clin. Invest.105, 271–278 (2000).
   PubMed Web of Science ®Google Scholar
• Haluzik M, Dietz KR, Kim JK et al. Adrenalectomy improves diabetes in A-ZIP/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity. Diabetes51, 2113–2118 (2002).
   PubMedGoogle Scholar
• Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med.7, 941–946 (2001).
   PubMed Web of Science ®Google Scholar
• Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin Lipidol.13, 51–59 (2002).
   PubMed Web of Science ®Google Scholar
• Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol. Res.53, 123–129 (2004).
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest.112, 1796–1808 (2003).
   PubMed Web of Science ®Google Scholar
• Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J. Clin. Invest.116, 33–35 (2006).
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr.100, 227–235 (2008).
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest.117, 175–184 (2007).
   PubMed Web of Science ®Google Scholar
• Imbeault P, Lemieux S, Prud’homme D et al. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism48, 355–362 (1999).
   PubMed Web of Science ®Google Scholar
• Dolinkova M, Dostalova I, Lacinova Z et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol. Cell. Endocrinol.291, 63–70 (2008).
   PubMedGoogle Scholar
• Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation108, 2460–2466 (2003).
   PubMed Web of Science ®Google Scholar
• Kremen J, Dolinkova M, Krajickova J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J. Clin. Endocrinol. Metab.91, 4620–4627 (2006).
   PubMed Web of Science ®Google Scholar
• Baker AR, Silva NF, Quinn DW et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol.5, 1 (2006).
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm. Metab. Res.40, 442–445 (2008).
   PubMed Web of Science ®Google Scholar
• Ouwens DM, Sell H, Greulich S et al. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J. Cell. Mol. Med.14(9), 2223-2234 (2010).
   PubMed Web of Science ®Google Scholar
• Ravussin E, Smith SR, Mitchell JA et al. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring)17, 1736–1743 (2009).
   PubMed Web of Science ®Google Scholar
• Haluzik M. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Curr. Opin Investig. Drugs6, 988–993 (2005).
   PubMedGoogle Scholar
• Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab.13, 84–89 (2002).
   PubMed Web of Science ®Google Scholar
• Picard F, Auwerx, J. PPAR(γ) and glucose homeostasis. Annu. Rev. Nutr.22, 167–197 (2002).
   PubMed Web of Science ®Google Scholar